J. Diebold et al., BONE-MARROW PATHOLOGY IN RELAPSING POLYCHONDRITIS - HIGH-FREQUENCY OFMYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 89(4), 1995, pp. 820-830
Haemopathologic changes were studied in 19 patients (13 male, six fema
le, age 33-85 years, mean 56 years) with relapsing polychondritis (RP)
. Anaemia was found in eight, thrombocytopenia in two and splenomegaly
in three patients. A total of 17 bone marrow biopsies were obtained f
rom seven individuals. Bone marrow evaluation revealed myelodysplastic
syndromes (MDS) with marked trilineage hyperplasia and dysplasia in t
hree cases. Since an excess of myeloblasts or an increase of CD34 posi
tive progenitor cells was not seen, the disorders were designated as '
refractory anaemia' or with regard to the dysplastic megakaryopoiesis
'MDS, unclassifiable'. Two of the three patients died after 10 and 55
months of follow-up due to infectious complications. In a further pati
ent, bone marrow analysis repeatedly showed an unexplained granulopoie
tic hyperplasia, which, however, was not dysplastic enough to allow a
diagnosis of MDS. The remaining patients had clearly reactive changes.
Our findings support the notion that RP is a heterogenous disorder an
d suggest that RP may at times represent a paraneoplastic phenomenon o
f an underlying MDS. Since HLA typing revealed a significantly increas
ed frequency of the antigen DR4 (10/17 patients positive=59%), we hypo
thesize that immunological imbalances due to the MDS in conjunction wi
th a specific immunogenetic background may play key roles in the patho
genesis of RP in these patients.